TrialSignal
Clinical trial intelligence report
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT00223509
Status
COMPLETED
Phase
PHASE4
Sponsor
The University of Texas Health Science Center at San Antonio
Executive brief
Investment-Ready Snapshot
* To evaluate the efficacy and safety of LAM+existing regimen of mood stabilizer in the acute treatment of patients in a mixed state of bipolar disorder. * To evaluate the efficacy and of a combination of LAM+existing regimen of mood stabilizers in the maintenance treatment of patients with mixed state of bipolar disorder
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00223509
Indication
Bipolar Disorder
Modality
small molecule
Target
Lamotrigine
Intervention
Lamotrigine
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.